直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Media Mention

Biologic Patents Need Specific Claim Parameters After Prometheus Case

July 23, 2012

The Pink Sheet

On a July 17 seminar on intellectual property sponsored by the Food and Drug Law Institute, Finnegan partner Richard B. Racine, spoke to how patent examiners can build a better patent.  “Number one, you have a claim process – if you don’t have a claim process, forget about it. Two, does the claim focus on a law of nature or a law of nature principle? So if those first two apply, then it says, does the claim include additional elements, steps … and is [it] practically applied? So, they say the claim must include additional elements or steps so that the inventor has practically applied or added something to the natural principle itself. So some integration of the steps beyond just looking at some natural principle.”  This implies that innovator companies seeking such patents should not be “applying conventional steps to the natural principle, like adding up stuff or measuring things, providing instructions or suing a machine just in a routine way that doesn’t add anything, he added.”  Mr. Racine also discussed specific claim parameters and biologics.

Related Practices

Global IP Enforcement, Litigation, and Trials

Prosecution and Portfolio Management

Related Industries

Life Sciences

Pharmaceutical

Related Professionals

Richard B. Racine
Senior Counsel
Washington, DC
+1 202 408 4038
Email

Related News

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Commentary

Quince Aims to Have ‘Dupe’ Evidence Shape Ugg Shoe Patent Trial

May 26, 2026

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Award/Ranking

Finnegan Wins IP Firm of the Year at the 2026 LSPN Awards

May 1, 2026

Press Release

Pvtech Secures Stay of New Jersey District Court Litigation Following USPTO Institution of All 10 Ex Parte Reexamination Requests Against Patents Asserted by Jiaxing Super Lighting

April 28, 2026

Press Release

Pvtech Achieves Perfect Record at USPTO: Institution of All 10 of 10 Ex Parte Reexamination Petitions Against Patents Asserted by Jiaxing Super Lighting

April 24, 2026

Commentary

Taylor Swift 'The Life of a Showgirl' Case Heads to Key May Hearing

April 22, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP